Journal
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 35, Issue 4, Pages 761-773Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2021.03.006
Keywords
BTK inhibitors; Toxicity; Side effects; Next-generation BTK inhibitors; CLL; Efficacy; Resistance